Literature DB >> 7696280

The effect of developmental changes in adolescence on drug disposition.

J W Finkelstein1.   

Abstract

Biological and behavioral change occurs throughout the lifespan. The nature and rapidity of change during adolescence is striking. The effects of rapid growth, sexual maturation, and psychological reorganization on pharmacodynamics and pharmacokinetics must be considered during studies on teenagers. It is important to consider the large amount of variability in the timing of normal developmental events. The concept of developmental rather than chronological age should be considered. Measurement of organismic and behavioral variables includes whole organism measures such as body height, weight, surface area, body mass index, self-concept, sexual identity/role, and many other behavioral measures. Pubertal development may be assessed by sexual maturity ratings. Bone age may be a particularly useful estimate of developmental status. Biochemical measures include gonadotropin, sex steroids, other hormonal or hormone receptor values.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696280     DOI: 10.1016/s1054-139x(94)90627-0

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  3 in total

Review 1.  Clinical pharmacology in the adolescent oncology patient.

Authors:  Gareth J Veal; Christine M Hartford; Clinton F Stewart
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

Review 2.  Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence.

Authors:  Mj Kennedy
Journal:  Clin Pharmacol Ther       Date:  2008-10-29       Impact factor: 6.875

3.  Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.

Authors:  John T Mondick; Brendan M Johnson; Lynda J Haberer; Mark E Sale; Peter C Adamson; Charles J Coté; James M Croop; Mark W Russo; Jeffrey S Barrett; J Frank Hoke
Journal:  Eur J Clin Pharmacol       Date:  2009-10-02       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.